UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
----------
Date of Report (Date of earliest event reported):
February 9, 2004
IMMUNOMEDICS, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-12104 61-1009366
(State or other (Commission (IRS Employer
jurisdiction File Number) Identification No.)
of incorporation)
300 American Road
Morris Plains, NJ 07950
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (973) 605-8200
Not applicable
(Former name or former address, if changed since last report)
- --------------------------------------------------------------------------------
Item 7. Financial Statements and Exhibits.
(c)
Exhibits.
99.1
Earnings release dated February 9, 2004 for the three and six months
ended December 31, 2003.
Item 9. Regulation FD Disclosure.
On February 9, 2004, Immunomedics, Inc. announced its financial results
for the three and six months ended December 31, 2003. The earnings release for
the interim periods is attached hereto as an exhibit to this current report on
Form 8-K and is being furnished pursuant to Item 12 of Form 8-K.
In accordance with the procedural guidance in SEC Release No. 33-8216, the
information in this Form 8-K and the Exhibit attached to this Form 8-K are being
furnished under "Item 9. Regulation FD Disclosure" in satisfaction of the
requirements of "Item 12. Disclosure of Results of Operations and Financial
Condition." The information shall not be deemed "filed" for purposes of Section
18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or the Exchange Act,
except as expressly set forth by specific reference in such a filing.
2
- --------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IMMUNOMEDICS, INC.
(Registrant)
Date: February 11, 2004 By: /s/ CYNTHIA L. SULLIVAN
-------------------------------------
Cynthia L. Sullivan
President and Chief Executive Officer
3
- --------------------------------------------------------------------------------
EXHIBIT INDEX
Exhibit
Number Description
- ------ -----------
99.1 Earnings release dated February 9, 2004 for the three and six months
ended December 31, 2003.
- --------------------------------------------------------------------------------